Cimdata Logo

Industry Summary Articles

Monday, March 28, 2022

Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference

Simulations Plus, Inc., a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced record-setting attendance and virtual content delivery for the 2022 MIDD+ Scientific Conference which was held February 16–17, 2022. The conference was focused on delivering real-world case studies using modeling and simulations. Tracks included dedicated sessions covering all stages of the drug development process, including Discovery, Pre-clinical, Clinical, and Post-Approval/Generics.

Shawn O’Connor , chief executive officer of Simulations Plus, said: “We were pleased with the momentum that carried forward from our inaugural MIDD+ event last year resulting in the record-setting attendance at this year’s MIDD+ Scientific Conference. As a leader in providing software tools and services to support the industry and our clients in their efforts to leverage modeling and simulation for more efficient and timely drug development, we were pleased to provide this virtual forum.”

The conference opened on February 16, with Rajanikanth Madabushi, Ph.D., Associate Director for Guidance and Scientific Policy, Office of Clinical Pharmacology, OTS/CDER at the U.S. Food and Drug Administration (FDA), delivering his keynote talk entitled, “Advancing Model-Informed Drug Development (MIDD): A Holistic and Integrative Approach.” On day two, speakers worldwide, including representatives from the U.S. FDA, the Brazilian regulatory agency ANVISA, Health Canada, and MHRA-UK, provided attendees with case studies and global regulatory perspectives on the development and validation of MIDD.

Other session topics ranged from building and validating machine-learning models and using population PK/PD approaches to support late-phase dose selection. Of note, the Women in Science roundtable, led by Cognigen’s Divisional President, Jill Fiedler-Kelly, highlighted meaningful topics for women within the scientific pharmaceutical industry including the power of mentorship, closing the STEM gap, and bringing your “authentic self” to the workplace. All talks are available for replay in the Simulations Plus Resource Center. 

Search for Simulations Plus on CIMdata.com

r
ipad background image

Featured Cimdata Reports

ipadcontent
PLM-Enabled Digital Transformation Benefits Appraisal Guide

The Guide is designed to help potential PLM users evaluate the applicability and payoffs of PLM in their enterprise, and to help existing users of PLM monitor the impact it is having on their product programs.

ipadcontent
Aerospace & Defense PLM Action Group

A CIMdata administered PLM advocacy group for the A&D industry

ipadcontent
PLM Market Analysis Reports

The PLM MAR Series provides detailed information and in-depth analysis on the worldwide PLM market. It contains analyses of major trends and issues, leading PLM providers, revenue analyses for geographical regions and industry sectors, and historical and projected data on market growth.

ipadcontent
PLM Market Analysis Country Reports

These reports offer country-specific analyses of the PLM market. Their focus is on PLM investment and use in industrial markets. Reports cover Brazil, France, Germany, India, Italy, Japan, Russia, South Korea, the United Kingdom, and the United States.

ipadcontent
Simulation & Analysis Market Analysis Report

This report presents CIMdata’s overview of the global simulation and analysis market, one of the fastest growing segments of the overall product lifecycle management market, including profiles of the leading S&A firms.

ipadcontent
CAM Market Analysis Report

CIMdata's definitive guide to the worldwide CAM software and services market. This comprehensive report provides critical intelligence on market size, user expenditures, trends, and segmentation, alongside authoritative rankings of the top CAM solution providers and reseller revenues.